Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Insmed Incorporated (IM8N.F) Follow Add holdings 59.00 -5.00 (-7.81%) As of 3:44:07 PM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for IM8N.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: IM8N.F View More All News Press Releases SEC Filings Insmed to Redeem $569.5 Million of Convertible Senior Notes Insmed Announces Redemption of all $569.5 Million of Remaining Outstanding 0.75% Convertible Senior Notes Due 2028 Insmed Incorporated (INSM): Among Takeover Rumors Hedge Funds Are Buying New England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Insmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025 Is Insmed Incorporated (INSM) the Best Long Term Growth Stock to Buy According to Billionaires? Insmed Incorporated (INSM): Insiders Were Dumping in Q1 2025 Is Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street Analysts Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference Insmed Incorporated (INSM): Among the Best Biotech Stocks to Buy According to Billionaires Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Related Tickers 7RG0.F Regulus Therapeutics Inc. 2.2800 +12.87% REGN34.SA Regeneron Pharmaceuticals, Inc. 56.08 +0.65% COV.V Covalon Technologies Ltd. 2.2600 -0.44% OABI OmniAb, Inc. 1.8250 -1.35% TECH Bio-Techne Corporation 50.64 +0.96% QURE uniQure N.V. 14.58 +1.32%